The Latest Breaking News from Evolent Health

Evolent Health beat earnings estimates and increased full-year guidance Tuesday evening. EVH stock jumped late.

The Dow Jones Industrial Average dived as much as 394 points Wednesday on a hot inflation report — the consumer price index.

 

Health care stock Evolent Health develops software to help care providers and payers control costs and deliver high value.

Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter:

Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24 hours, at $27.84 per share.

Upgrades

In an SEC filing, Cook County named Evolent Health Inc (NYSE:EVH) the sole third-party administrator for CountyCare Health Plan from fiscal 2023 through fiscal 2025. Piper Sandler analyst Jessica Tassan notes that the award extends a contract Evolent has held since fiscal 2018 to provide administrative simplification services to support CountyCare's 425,000 Medicaid…

Evolent Health (NYSE:EVH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:02 PM. Here's what investors need to know about the announcement.